Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Galantamine + Sertraline Versus Galantamine, Sertraline, and Placebo in Obese Subjects
2007-000762-20Phase 2Completed
- Sponsor
- Theracos, Inc.
- Start
- Jul 2007
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of galantamine and sertraline in obesity (4 arms), sponsored by Theracos, Inc. Primary endpoints: Percent change from baseline body weight and Safety and tolerability. Started Jul 2007; status: completed.
02
Drugs
galantaminesertraline
03
Conditions
obesity
Beyond the preview
Go deeper on 2007-000762-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000762-20.